These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD Elife; 2020 Oct; 9():. PubMed ID: 33112236 [TBL] [Abstract][Full Text] [Related]
5. Clinical validation of SARS-CoV-2 electrochemical immunosensor based on the spike-ACE2 complex. Vásquez V; Orozco J J Virol Methods; 2024 Jun; 327():114940. PubMed ID: 38608761 [TBL] [Abstract][Full Text] [Related]
6. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain. Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438 [TBL] [Abstract][Full Text] [Related]
7. Amplified parallel antigen rapid test for point-of-care salivary detection of SARS-CoV-2 with improved sensitivity. Tng DJH; Yin BCY; Cao J; Ko KKK; Goh KCM; Chua DXW; Zhang Y; Chua MLK; Low JGH; Ooi EE; Soo KC Mikrochim Acta; 2021 Dec; 189(1):14. PubMed ID: 34870771 [TBL] [Abstract][Full Text] [Related]
8. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity. Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996 [TBL] [Abstract][Full Text] [Related]
9. Epitope-Functionalized Gold Nanoparticles for Rapid and Selective Detection of SARS-CoV-2 IgG Antibodies. Lew TTS; Aung KMM; Ow SY; Amrun SN; Sutarlie L; Ng LFP; Su X ACS Nano; 2021 Jul; 15(7):12286-12297. PubMed ID: 34133128 [TBL] [Abstract][Full Text] [Related]
10. Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein. Shi Y; Zeida A; Edwards CE; Mallory ML; Sastre S; Machado MR; Pickles RJ; Fu L; Liu K; Yang J; Baric RS; Boucher RC; Radi R; Carroll KS Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35074895 [TBL] [Abstract][Full Text] [Related]
11. Rapid SARS-CoV-2 Spike Protein Detection by Carbon Nanotube-Based Near-Infrared Nanosensors. Pinals RL; Ledesma F; Yang D; Navarro N; Jeong S; Pak JE; Kuo L; Chuang YC; Cheng YW; Sun HY; Landry MP Nano Lett; 2021 Mar; 21(5):2272-2280. PubMed ID: 33635655 [TBL] [Abstract][Full Text] [Related]
12. Generation and utility of a single-chain fragment variable monoclonal antibody platform against a baculovirus expressed recombinant receptor binding domain of SARS-CoV-2 spike protein. Salem R; El-Kholy AA; Waly FR; Ayman D; Sakr A; Hussein M Mol Immunol; 2022 Jan; 141():287-296. PubMed ID: 34915268 [TBL] [Abstract][Full Text] [Related]
13. Single-step, wash-free digital immunoassay for rapid quantitative analysis of serological antibody against SARS-CoV-2 by photonic resonator absorption microscopy. Zhao B; Che C; Wang W; Li N; Cunningham BT Talanta; 2021 Apr; 225():122004. PubMed ID: 33592744 [TBL] [Abstract][Full Text] [Related]
14. Development of Nanobody-Displayed Whole-Cell Biosensors for the Colorimetric Detection of SARS-CoV-2. He Y; Xu Z; Kasputis T; Zhao X; Ibañez I; Pavan F; Bok M; Malito JP; Parreno V; Yuan L; Wright RC; Chen J ACS Appl Mater Interfaces; 2023 Aug; 15(31):37184-37192. PubMed ID: 37489943 [TBL] [Abstract][Full Text] [Related]
15. Single-particle rotational sensing for analyzing the neutralization activity of antiviral antibodies. Shang J; Li H; Liu X; Sun S; Huan S; Xiong B Talanta; 2024 Nov; 279():126606. PubMed ID: 39089080 [TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions. Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP mBio; 2021 Mar; 12(2):. PubMed ID: 33785634 [TBL] [Abstract][Full Text] [Related]
17. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein. Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194 [TBL] [Abstract][Full Text] [Related]
18. One-step synthesized multisize AuAg alloy nanoparticles with high SERS sensitivity in directly detecting SARS-CoV-2 spike protein. Qin Z; Liu Y; Jia X; Zhou J; Li H; Wang X; Zhang S; Chang H; Wang G Anal Chim Acta; 2024 Aug; 1317():342919. PubMed ID: 39030015 [TBL] [Abstract][Full Text] [Related]
19. Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant. Graham C; Seow J; Huettner I; Khan H; Kouphou N; Acors S; Winstone H; Pickering S; Galao RP; Dupont L; Lista MJ; Jimenez-Guardeño JM; Laing AG; Wu Y; Joseph M; Muir L; van Gils MJ; Ng WM; Duyvesteyn HME; Zhao Y; Bowden TA; Shankar-Hari M; Rosa A; Cherepanov P; McCoy LE; Hayday AC; Neil SJD; Malim MH; Doores KJ Immunity; 2021 Jun; 54(6):1276-1289.e6. PubMed ID: 33836142 [TBL] [Abstract][Full Text] [Related]
20. Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis. Gorshkov K; Susumu K; Chen J; Xu M; Pradhan M; Zhu W; Hu X; Breger JC; Wolak M; Oh E ACS Nano; 2020 Sep; 14(9):12234-12247. PubMed ID: 32845122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]